INMD - Sell-siders like InMode in premarket analyst action September, 03 2019 08:49 AM InMode Ltd. Correvio Pharma (NASDAQ:CORV) initiated with Overweight rating and $6 (193% upside) price target at Cantor Fitzgerald.More news on: Correvio Pharma Corp., InMode Ltd., MeiraGTx Holdings plc, Healthcare stocks news, Stocks on the move, , Read more ...